Chamberlain RS, Huber K, White JC et al (1999) Apocrine gland carcinoma of the axilla: review of the literature and recommendations for treatment. Am J Clin Oncol 22:131–135

Article  PubMed  CAS  Google Scholar 

Hollowell KL, Agle SC, Zervos EE et al (2012) Cutaneous apocrine adenocarcinoma: defining epidemiology, outcomes, and optimal therapy for a rare neoplasm. J Surg Oncol 105:415–419

Article  PubMed  Google Scholar 

Piris A, Peng Y, Boussahmain C et al (2014) Cutaneous and mammary apocrine carcinomas have different immunoprofiles. Hum Pathol 45:320–326

Article  PubMed  CAS  Google Scholar 

Robson A, Lazar AJF, Ben Nagi J et al (2008) Primary cutaneous apocrine carcinoma: a clinico-pathologic analysis of 24 cases. Am J Surg Pathol 32:682–690

Article  PubMed  Google Scholar 

Japanese breast cancer society (2018) General rules for clinical and pathological recording of breast cancer, 18th edn. Kanehara Shuppan, Tokyo

Google Scholar 

Japanese breast cancer society (2022) Clinical practice guidelines for systemic treatment of breast cancer, 2022nd edn. Kanehara Shuppan, Tokyo

Google Scholar 

Mori T, Teraoka H, Kinoshita H et al (2018) A case of apocrine carcinoma in the breast that was difficult to distinguish from axillary apocrine adenocarcinoma. Gan To Kagaku Ryoho 45:1961–1963

PubMed  Google Scholar 

Toledo-Pastrana T, Llombart-Cussac B, Traves-Zapata V et al (2014) Case report: differential diagnosis between primary cutaneous apocrine adenocarcinoma versus extramammary or metastatic breast adenocarcinoma. Am J Dermatopathol 36:e175–e178

Article  PubMed  Google Scholar 

Fernandez-Flores A (2010) Primary cutaneous apocrine carcinoma versus metastasis, a plea to the dermatopathology community. Am J Dermatopathol 32:853–854

Article  PubMed  Google Scholar 

Ackerman AB, Kessler G, Gyorfi T et al (2007) Contrary view: the breast is not an organ per se, but a distinctive region of skin and subcutaneous tissue. Am J Dermatopathol 29:211–218

Article  PubMed  Google Scholar 

Tsuruta S, Ogata D, Namikawa K et al (2023) Prognostic factors in cutaneous apocrine carcinoma: a single-institution retrospective study of 32 patients. Int J Clin Oncol 28:1690–1696

Article  PubMed  Google Scholar 

Ogata D, Kiyohara Y, Yoshikawa S et al (2014) Treatment strategy for cutaneous apocrine carcinoma. Int J Clin Oncol 19:712–715

Article  PubMed  CAS  Google Scholar 

Ogata D, Takeuchi H, Shiomi Y et al (2018) Metastatic cutaneous apocrine carcinoma: a multidisciplinary approach incorporating endocrine therapy. Eur J Dermatol 28:415–417

Article  PubMed  Google Scholar 

Goldstein R, Stefanato CM, Warbey V et al (2012) Advanced vulvar apocrine carcinoma expressing estrogen receptors that responds to tamoxifen therapy. Future Oncol 8:1199–1203

Article  PubMed  CAS  Google Scholar 

Otsuka M, Yamasaki O, Kaji T et al (2016) Metastatic cutaneous apocrine adenocarcinoma treated with a combination of pertuzumab-based targeted therapy and taxane chemotherapy: a case report. JAMA Dermatol 152:111–113

Article  PubMed  Google Scholar 

Hidaka T, Fujimura T, Watabe A et al (2012) Successful treatment of HER-2-positive metastatic apocrine carcinoma of the skin with lapatinib and capecitabine. Acta Derm Venerol 92:654–655

Article  PubMed  CAS  Google Scholar 

Hirano-Lotman Y, Ishida Y, Endo Y et al (2023) Cutaneous adnexal adenocarcinoma: genomic analysis and successful HER2–targeted therapy of metastatic disease. Acta Derm Venereol 103:adv9399

Article  PubMed  Google Scholar